{"id":"estetrol-oral-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Vaginal bleeding irregularities"}]},"_chembl":{"chemblId":"CHEMBL6068423","moleculeType":"Small molecule","molecularWeight":"322.40"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Estetrol is a naturally occurring estrogen metabolite that acts as a selective estrogen receptor modulator, activating estrogen receptors in a tissue-selective manner. Unlike conventional estrogens used in hormone therapy, estetrol may provide beneficial estrogenic effects while potentially reducing risks associated with traditional estrogen-based therapies. It is being developed as an oral contraceptive and for hormone replacement therapy applications.","oneSentence":"Estetrol is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors to provide estrogenic activity with a potentially improved safety profile.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:11:36.568Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Oral contraception"},{"name":"Hormone replacement therapy in menopausal women"}]},"trialDetails":[{"nctId":"NCT04090957","phase":"PHASE3","title":"Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)","status":"COMPLETED","sponsor":"Estetra","startDate":"2019-09-27","conditions":"Vasomotor Symptoms, Menopausal Symptoms","enrollment":1015},{"nctId":"NCT04209543","phase":"PHASE3","title":"Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)","status":"COMPLETED","sponsor":"Estetra","startDate":"2019-12-30","conditions":"Vasomotor Symptoms, Menopausal Symptoms","enrollment":1570},{"nctId":"NCT04792385","phase":"PHASE3","title":"Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents","status":"COMPLETED","sponsor":"Estetra","startDate":"2020-12-28","conditions":"Safety","enrollment":145},{"nctId":"NCT04819906","phase":"PHASE1","title":"Effect of Estetrol Monohydrate (E4) on QTc Interval","status":"COMPLETED","sponsor":"Estetra","startDate":"2021-03-09","conditions":"Prolonged QTc Interval","enrollment":32},{"nctId":"NCT03091595","phase":"PHASE2","title":"E4/DRSP Ovarian Function Inhibition Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2017-02-07","conditions":"Prevention of Pregnancy","enrollment":82},{"nctId":"NCT05677035","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects","status":"COMPLETED","sponsor":"Hyundai Pharm","startDate":"2022-01-11","conditions":"Contraception","enrollment":20},{"nctId":"NCT04801836","phase":"PHASE2","title":"Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection","status":"UNKNOWN","sponsor":"NEURALIS s.a.","startDate":"2020-11-19","conditions":"Covid19","enrollment":162},{"nctId":"NCT03361969","phase":"PHASE2","title":"Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.","status":"COMPLETED","sponsor":"Pantarhei Oncology B.V.","startDate":"2018-04-16","conditions":"Prostatic Neoplasm","enrollment":63},{"nctId":"NCT02817841","phase":"PHASE3","title":"E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-08-30","conditions":"Contraception","enrollment":2148},{"nctId":"NCT02817828","phase":"PHASE3","title":"E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-06","conditions":"Contraception","enrollment":1577},{"nctId":"NCT03798197","phase":"PHASE1","title":"Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers","status":"COMPLETED","sponsor":"Donesta Bioscience","startDate":"2019-01-30","conditions":"Food-effect","enrollment":28},{"nctId":"NCT03512860","phase":"PHASE1","title":"Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study","status":"COMPLETED","sponsor":"Estetra","startDate":"2018-04-12","conditions":"Contraception","enrollment":24},{"nctId":"NCT02957630","phase":"PHASE1, PHASE2","title":"\"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study\"","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-09","conditions":"Contraception, Liver Metabolism, Hemostasis Parameter","enrollment":101},{"nctId":"NCT01221831","phase":"PHASE2","title":"Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2","status":"COMPLETED","sponsor":"Estetra","startDate":"2010-09","conditions":"Contraception","enrollment":396}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["E4 oral tablet"],"phase":"phase_3","status":"active","brandName":"Estetrol oral tablet","genericName":"Estetrol oral tablet","companyName":"Estetra","companyId":"estetra","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Estetrol is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors to provide estrogenic activity with a potentially improved safety profile. Used for Oral contraception, Hormone replacement therapy in menopausal women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}